使用Apollo可分离头端微导管对动静脉畸形和动静脉瘘进行血管内栓塞
该回顾性研究分析了2个三级脑血管中心61例患者共177次使用Apollo可分离头端微导管的栓塞操作,结果显示微导管置入成功率高、闭塞率高、并发症率和死亡率低,微导管头端分离与高闭塞率独立相关。
要点
- 61例患者共177次栓塞,微导管置入成功172支供血动脉,头端分离发生率为19.2%(33/172)。
- 45.9%(28/61)的患者达到≥75%的病灶闭塞,86.9%(53/61)的患者功能预后良好(改良Rankin量表评分0-2分)。
- 多因素分析中,微导管头端分离是唯一与高闭塞率(>90%)独立相关的变量(OR 9.5;p=0.03)。
核心结论
- 使用Apollo可分离头端微导管栓塞动静脉畸形和动静脉瘘与高置管成功率、高闭塞率及低并发症率和死亡率相关。
- 所有病例中微导管均成功回收,即使在远端分支供血动脉长时间注射且常伴明显反流的情况下。
- 本研究是Apollo微导管用于神经介入操作的最大病例系列。
研究设计与样本
- 回顾性研究,检索2个三级脑血管中心(Barrow Neurological Institute和University of Pittsburgh Medical Center)的患者数据库。
- 纳入使用Apollo微导管进行动静脉畸形或动静脉瘘血管内栓塞的患者,收集人口学资料和病灶特征。
- 分析Apollo专用血管内变量,包括微导管置入次数、治疗次数、栓塞供血动脉数、微导管头端分离状态、闭塞率及血管内和微导管相关并发症率和死亡率。
主要发现
- 2014年7月至2016年10月,61例患者(平均年龄40.3岁)共进行177次使用Apollo微导管的栓塞操作。
- 最常见表现为出血(22/61,36.1%);多数病灶为动静脉畸形(51/61,83.6%;平均直径30.6 mm),平均Spetzler-Martin分级为2.4。
- 51例动静脉畸形患者中39例(76.5%)接受了切除术;大多数患者(50/61,82%)接受单次栓塞治疗,每次治疗平均栓塞供血动脉数为2.5(范围1-7)。
- 172次栓塞中,使用Onyx-18者103次(59.9%),使用N-butyl cyanoacrylate(NBCA)者44次(25.6%),使用Onyx-34者25次(14.5%)。
- 45.9%(28/61)的患者达到≥75%的病灶闭塞;微导管头端分离发生于19.2%(33/172)的微导管;86.9%(53/61)的患者功能预后良好(改良Rankin量表评分0-2分)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Liquid embolic agents have revolutionized endovascular management of arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs). Nonetheless, since 2005, the US FDA has received more than 100 reports of microcatheter breakage or entrapment related to Onyx embolization, including 9 deaths. In 2014, the Apollo detachable-tip microcatheter became the first of its kind available in the US. Since then, few reports on its safety have been published. METHODS: The authors conducted a retrospective review of endovascular cases by searching the patient databases at 2 tertiary cerebrovascular centers (Barrow Neurological Institute and University of Pittsburgh Medical Center). Patients who underwent endovascular embolization of an AVM or AVF using the Apollo microcatheter were identified. Patient demographics and lesion characteristics were collected. The authors analyzed Apollo-specific endovascular variables, such as number of microcatheterizations, sessions, and pedicles embolized; microcatheter tip detachment status; obliteration rate; and endovascular- and microcatheter-related morbidity and mortality. RESULTS: From July 2014 to October 2016, a total of 177 embolizations using the Apollo microcatheter were performed in 61 patients (mean age 40.3 years). The most frequent presentation was hemorrhage (22/61, 36.1%). Most lesions were AVMs (51/61, 83.6%; mean diameter 30.6 mm). The mean Spetzler-Martin grade was 2.4. Thirty-nine (76.5%) of 51 patients with AVMs underwent resection. Microcatheterization was successful in 172 pedicles. Most patients (50/61, 82%) underwent a single embolization session. The mean number of pedicles per session was 2.5 (range 1-7). Onyx-18 was used in 103 (59.9%), N-butyl cyanoacrylate (NBCA) in 44 (25.6%), and Onyx-34 in 25 (14.5%) of the 172 embolizations. In 45.9% (28/61) of the patients, lesion obliteration of 75% or greater was achieved. Tip detachment occurred in 19.2% (33/172) of microcatheters. Fifty-three (86.9%) of the 61 patients who underwent embolization with the Apollo microcatheter had good functional outcomes (modified Rankin Scale score 0-2). No unintended microcatheter fractures or related morbidity was observed. One patient died of intraprocedural complications unrelated to microcatheter selection. In the univariate analysis, microcatheter tip detachment (p = 0.12), single embolized pedicles (p = 0.12), and smaller AVM nidus diameter (p = 0.17) correlated positively with high obliteration rates (> 90%). In the multivariate analysis, microcatheter tip detachment was the only independent variable associated with high obliteration rates (OR 9.5; p = 0.03). CONCLUSIONS: The use of the Apollo detachable-tip microcatheter for embolization of AVMs and AVFs is associated with high rates of successful catheterization and obliteration and low rates of morbidity and mortality. The microcatheter was retrieved in all cases, even after prolonged injections in distal branch pedicles, often with significant reflux. This study represents the largest case series on the application of the Apollo microcatheter for neurointerventional procedures.
引用
- Flores BC, See AP, Weiner GM, et al. Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas. J Neurosurg. 2018. PMID: 29570006. doi:10.3171/2017.9.JNS17397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。